Target intelligence / Profile preview

Novel transcript, antisense to USP51

Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript
01

Overview

This gene encodes a long non-coding RNA (lncRNA) that is transcribed in the antisense orientation to the USP51 gene. Antisense lncRNAs frequently play regulatory roles in controlling expression of their associated sense genes, often through mechanisms involving chromatin modulation, transcription interference, or direct RNA interactions. While this specific transcript (ENSG00000288739) does not have a well-characterized function, antisense transcription in general can locally modify chromatin architecture, regulate transcription rates, and potentially affect gene expression of USP51. No clinical or drug interaction data are available for this target, and it is not currently classified as a therapeutic target.

Other names
lnc-USP51-2ENSG00000288739Novel antisense transcript to USP51
02

Mechanism of action

Chromatin modification (by analogy with the broader class of antisense RNAs; lncRNAs can recruit chromatin modifiers or impact chromatin status near their sense gene targets) Regulation of sense (USP51) gene expression (general role inferred for antisense lncRNAs)

03

Biological functions

Epigenetic regulation (by analogy with other antisense lncRNAs)Regulation of sense transcription and chromatin state (general for antisense lncRNAs)
04

Disease associations

Other (no direct disease association currently established for this transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to USP51.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to USP51.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call